Xarelto Lawsuit Help - Home | FacebookIn comparison, warfarin can easily be reversed with a dose of Vitamin K.The cases are condensed into a MDL in the Eastern District Federal Court of Louisiana.
Cases continue to enter into the court system against Xarelto.The judge overseeing the cases requests that 40 cases be seleted for Bellwether hearings.As of April 2017, around 17,000 Xarelto lawsuits were pending nationwide.Every case has alleged that the manufacturers and developers of Xarelto were aware of these significant dangers from their medication but failed to provide the medical industry and the public with that knowledge.
First Xarelto Bellwether Trial Kicks Off in New OrleansTimeline of Xarelto litigation events, fda filings and general medical news for family and patients of the anticoagulant.
Xarelto does not require continual monitoring to be effective.Janssen Pharmaceuticals, a division of Johnson and Johnson, and Bayer Pharmaceuticals, have been named as the Defendants in the lawsuits against Xarelto.
Find the latest information about Xarelto lawsuits and how to file for your compensation.Blood-thinning drug Xarelto faces 18,000 lawsuits. by Jon Rappoport.
Xarelto Lawsuit Bellwether Trial Dates Set For Early 2017The first lawsuit is filed against the manufacturers and developers of Xarelto.
Xarelto Litigation Moving Toward 2017 Trial DatesXarelto becomes the second highest prescribed blood thinning medication over the next several months due to the almost immediate complications being experienced by a similar blood thinning medication, Pradaxa.A defective INR-testing device used to calibrate warfarin dosage may have skewed results of the ROCKET-AF clinical trial in favor of Xarelto.The FDA approves Xarelto for the prevention of strokes and heart attacks in patients that suffer from arterial fibrillation (A Fib).
Xarelto Lawsuit | Xarelto Lawsuit InformationAt this time, the manufacturers of Xarelto were trying to gain approval for the medications use in treating ACS.The FDA found horrendous distortions in the clinical trials of Xarelto—and yet the agency approved the drug, as safe and effective, for public use.Xarelto Litigation Moving Toward 2017 Trial Dates. In addition to the bleeding risks, a new concern about Xarelto emerged in a recent lawsuit filing.
Sanders Phillips Grossman and its predecessors have recovered over one.Warfarin requires continual medical monitoring through blood tests to ensure that the dosage being used is correct.Company continues to aggressively market the medication despite all the adverse events.ROCKET-AF was a pivotal clinical trial that compared Xarelto to wafarin.Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.Click here for Xarelto Class Action Lawsuit Information - Free Case Review: (866) 588-0600.Xarelto has also been linked to higher rates of bleeding than Pradaxa.This causes organs to shut down because they do not receive blood they need to survive.All of the lawsuits accuse drug-makers of downplaying the risk of uncontrollable bleeding.
Loss of controls of some muscles has been reported, and spontaneous clotting that has led to stroke and death, the very thing that Xarelto was meant to prevent.Xarelto, generic name Rivaroxaban, is one of the newest anti-coagulant medications to enter the market.
Since its emergence as a blood thinning medication, Xarelto has been associated with severe side effects due to uncontrollable bleeding, unusual blood clotting, and death.
Latest Pradaxa News, Lawsuit and Side Effects Update for 2017
IVC Filter Lawsuit 2017. Complications? Your Options..Xarelto is one of the newest blood thinning medications to enter the medical market.
Xarelto Multidistrict Litigation Moves Toward BellwetherIf you or somebody you know has been diagnosed with severe bleeding, you should contact our lawyers immediately for a free case consultation.Only eight days after its approval, the American Health Association publishes and article in their trade journal stating that there is no antidote for the drug Xarelto.
Only 18 months after being released to the public, the FDA is reporting that over 600 adverse events have been reported.The judge overseeing the federal litigation has appointed 12 attorneys to leadership roles and set the first four trial dates for February 2017.